688767 博拓生物
已收盘 10-09 15:00:00
资讯
新帖
简况
诺奖光遗传学技术引产业关注，国内多条神经基因治疗管线加速推进
中金财经 · 10-06
诺奖光遗传学技术引产业关注，国内多条神经基因治疗管线加速推进
博拓生物（688767）9月29日主力资金净买入305.47万元
证券之星 · 09-30
博拓生物（688767）9月29日主力资金净买入305.47万元
9月21日杭州博拓生物科技涨6.11%，广发医药创新混合发起式A基金重仓该股
证券之星 · 09-21
9月21日杭州博拓生物科技涨6.11%，广发医药创新混合发起式A基金重仓该股
博拓生物上半年净利转亏 2021上市募9亿国泰海通保荐
中金财经 · 09-10
博拓生物上半年净利转亏 2021上市募9亿国泰海通保荐
每周股票复盘：博拓生物（688767）将召开股东会审议股权激励计划
证券之星 · 09-06
每周股票复盘：博拓生物（688767）将召开股东会审议股权激励计划
股市必读：博拓生物新发布《2026年第二次临时股东会会议资料》
证券之星 · 09-04
股市必读：博拓生物新发布《2026年第二次临时股东会会议资料》
股市必读：博拓生物新发布《2026年第二次临时股东会会议资料》
证券之星 · 09-03
股市必读：博拓生物新发布《2026年第二次临时股东会会议资料》
博拓生物（688767）披露2026年半年度报告，8月31日股价上涨4.35%
证券之星 · 08-31
博拓生物（688767）披露2026年半年度报告，8月31日股价上涨4.35%
股市必读：博拓生物中报 - 第二季度单季净利润同比下降272.88%
证券之星 · 08-31
股市必读：博拓生物中报 - 第二季度单季净利润同比下降272.88%
博拓生物（688767）2026年中报简析：增收不增利，三费占比上升明显
证券之星 · 08-30
博拓生物（688767）2026年中报简析：增收不增利，三费占比上升明显
博拓生物(688767)6月30日股东户数0.64万户，较上期减少20.95%
证券之星 · 08-29
博拓生物(688767)6月30日股东户数0.64万户，较上期减少20.95%
图解博拓生物中报：第二季度单季净利润同比下降272.88%
证券之星 · 08-29
图解博拓生物中报：第二季度单季净利润同比下降272.88%
8月12日博拓生物涨5.00%，广发医药创新混合发起式A基金重仓该股
证券之星 · 08-12
8月12日博拓生物涨5.00%，广发医药创新混合发起式A基金重仓该股
博拓生物新注册《IMReader型胶体金免疫层析分析处理软件V1.0》项目的软件著作权
证券之星 · 08-04
博拓生物新注册《IMReader型胶体金免疫层析分析处理软件V1.0》项目的软件著作权
7月27日博拓生物涨8.30%，广发医药创新混合发起式A基金重仓该股
证券之星 · 07-27
7月27日博拓生物涨8.30%，广发医药创新混合发起式A基金重仓该股
四张牌集齐一个王炸，博拓生物All in脑机接口
中金财经 · 06-15
四张牌集齐一个王炸，博拓生物All in脑机接口
博拓生物已回购159万股 金额5940万元
财中社 · 06-09
博拓生物已回购159万股 金额5940万元
博拓生物（688767）披露2025年年度权益分派实施后调整回购股份价格上限的公告，6月2日股价上涨1.16%
证券之星 · 06-02
博拓生物（688767）披露2025年年度权益分派实施后调整回购股份价格上限的公告，6月2日股价上涨1.16%
博拓生物（688767）披露以集中竞价交易方式首次回购公司股份暨回购进展公告，6月1日股价上涨1.6%
证券之星 · 06-01
博拓生物（688767）披露以集中竞价交易方式首次回购公司股份暨回购进展公告，6月1日股价上涨1.6%
每周股票复盘：博拓生物（688767）每股派现0.7元
证券之星 · 05-31
每周股票复盘：博拓生物（688767）每股派现0.7元
加载更多
公司概况
公司名称：
杭州博拓生物科技股份有限公司
所属行业：
医药制造业
上市日期：
2021-09-08
主营业务：
杭州博拓生物科技股份有限公司的主营业务是即时检测试剂及仪器的研发、生产与销售。公司的主要产品是药物滥用（毒品）检测系列、传染病检测系列、生殖健康检测系列、肿瘤标志物检测系列、心肌标志物检测系列、抗原/抗体生物原料、动物疾病检测平台系列、炎症系列、分子诊断平台系列。
发行价格：
34.55
{"stockData":{"symbol":"688767","market":"SH","secType":"STK","nameCN":"博拓生物","latestPrice":39.6,"timestamp":1791529200000,"preClose":40.38,"halted":0,"volume":3411443,"delay":0,"changeRate":-0.0193,"floatShares":149000000,"shares":149000000,"eps":0.136,"marketStatus":"已收盘","change":-0.78,"latestTime":"10-09 15:00:00","open":39.94,"high":41.25,"low":38.16,"amount":134000000,"amplitude":0.0765,"askPrice":39.67,"askSize":38,"bidPrice":39.6,"bidSize":22,"shortable":0,"etf":0,"ttmEps":0.136,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1791768600000},"marketStatusCode":5,"adr":0,"adjPreClose":40.38,"symbolType":"stock_kcb","openAndCloseTimeList":[[1791509400000,1791516600000],[1791522000000,1791529200000]],"highLimit":44.42,"lowLimit":36.34,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":149333334,"isCdr":false,"pbRate":2.76,"roa":"--","peRate":291.176471,"roe":"--","epsLYR":0.34,"committee":0.050847,"marketValue":5914000000,"turnoverRate":0.0228,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-10-12。","afterMarket":{"amount":0,"volume":0,"close":39.6,"buyVolume":0,"sellVolume":0,"time":1791531237746,"indexStatus":"已收盘 10-09 15:30:00","preClose":40.38},"floatMarketCap":5914000000},"requestUrl":"/m/hq/s/688767","defaultTab":"news","newsList":[{"id":"2673051766","title":"诺奖光遗传学技术引产业关注，国内多条神经基因治疗管线加速推进","url":"https://stock-news.laohu8.com/highlight/detail?id=2673051766","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673051766?lang=zh_cn&edition=full","pubTime":"2026-10-06 21:30","pubTimestamp":1791293401,"startTime":"0","endTime":"0","summary":"近日，2026 年诺贝尔生理学或医学奖正式揭晓，表彰科学家在光遗传学领域的开创性研究成果，这项颠覆性底层技术火速出圈，引爆资本市场与生物医药行业关注，带动脑科学、神经基因治疗赛道热度全面攀升。业内人士分析，本次诺奖权威背书，将大幅加速光遗传学技术的科研转化与产业普及，进一步兑现赛道价值。","market":"hk","thumbnail":" http://caiji.3g.cnfol.com/colect/202610/06/20261006119145.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202610/06/20261006119145.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20261006/32388712.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0236","301293","BK0175","BK0216","BK0060","BK0183","BK0028","BK0096","BK0196","BK0187","BK0188","600196","688767","300683","603127","BK0239","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671252312","title":"博拓生物（688767）9月29日主力资金净买入305.47万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2671252312","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671252312?lang=zh_cn&edition=full","pubTime":"2026-09-30 08:31","pubTimestamp":1790728268,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年9月29日收盘，博拓生物报收于40.46元，下跌2.03%，换手率1.24%，成交量1.84万手，成交额7504.1万元。近5日资金流向一览见下表：博拓生物融资融券信息显示，融资方面，当日融资买入1481.63万元，融资偿还891.12万元，融资净买入590.51万元，连续3日净买入累计1515.35万元。博拓生物主营业务：研发、生产和销售高质量的POCT诊断试剂产品。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000006731.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688767"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669159935","title":"9月21日杭州博拓生物科技涨6.11%，广发医药创新混合发起式A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2669159935","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669159935?lang=zh_cn&edition=full","pubTime":"2026-09-21 16:43","pubTimestamp":1789980185,"startTime":"0","endTime":"0","summary":"证券之星消息，9月21日杭州博拓生物科技涨6.11%创60日新高，收盘报43.44元，换手率3.7%，成交量5.53万手，成交额2.37亿元。重仓杭州博拓生物科技的公募基金请见下表：该股最近90天内共有2家机构给出评级，买入评级2家。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为广发基金的广发医药创新混合发起式A。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092100020936.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688767","BK0239","BK1515","BK1161","BK1574","09939","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666430569","title":"博拓生物上半年净利转亏 2021上市募9亿国泰海通保荐","url":"https://stock-news.laohu8.com/highlight/detail?id=2666430569","media":"中金财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666430569?lang=zh_cn&edition=full","pubTime":"2026-09-10 16:57","pubTimestamp":1789030626,"startTime":"0","endTime":"0","summary":"中国经济网北京9月10日讯 博拓生物 近期发布2026年半年度报告。2026年上半年，公司实现营业收入2.15亿元，同比增长5.61%；归属于上市公司股东的净利润-1655.26万元，去年同期为1240.24万元；归属于上市公司股东的扣除非经常性损益的净利润-2080.19万元，去年同期为683.48万元；经营活动产生的现金流量净额为811.44万元。 博拓生物首次公开发行募集资金总额为9.21亿元，募集资金净额为8.29亿元，较原拟募资少6207.81万元。","market":"fut","thumbnail":" http://caiji.3g.cnfol.com/colect/202609/10/20260910129553.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202609/10/20260910129553.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260910/32366180.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0012","601211","BK0239","BK0276","BK1564","BK1147","BK0184","BK0188","IPOS","688767","02611","BK0183","BK0028","BK0201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665365044","title":"每周股票复盘：博拓生物（688767）将召开股东会审议股权激励计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2665365044","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665365044?lang=zh_cn&edition=full","pubTime":"2026-09-06 02:44","pubTimestamp":1788633849,"startTime":"0","endTime":"0","summary":"截至2026年9月4日收盘，博拓生物报收于37.5元，较上周的37.0元上涨1.35%。本周关注点公司公告汇总：博拓生物将于2026年9月14日召开临时股东会，审议2026年限制性股票激励计划及相关议案。公司公告汇总杭州博拓生物科技股份有限公司将于2026年9月14日召开第二次临时股东会，审议《公司2026年限制性股票激励计划（草案）》及其摘要、《公司2026年限制性股票激励计划实施考核管理办法》及提请股东会授权董事会办理股权激励相关事宜的议案。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090600000824.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688767"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664806408","title":"股市必读：博拓生物新发布《2026年第二次临时股东会会议资料》","url":"https://stock-news.laohu8.com/highlight/detail?id=2664806408","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664806408?lang=zh_cn&edition=full","pubTime":"2026-09-04 02:14","pubTimestamp":1788459252,"startTime":"0","endTime":"0","summary":"公司公告汇总：博拓生物将于2026年9月14日召开第二次临时股东会，审议2026年限制性股票激励计划相关议案。公司公告汇总2026年第二次临时股东会会议资料杭州博拓生物科技股份有限公司将于2026年9月14日召开第二次临时股东会，审议《公司2026年限制性股票激励计划（草案）》及其摘要、《公司2026年限制性股票激励计划实施考核管理办法》及提请股东会授权董事会办理股权激励相关事宜的议案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090400002545.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688767"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664684537","title":"股市必读：博拓生物新发布《2026年第二次临时股东会会议资料》","url":"https://stock-news.laohu8.com/highlight/detail?id=2664684537","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664684537?lang=zh_cn&edition=full","pubTime":"2026-09-03 01:49","pubTimestamp":1788371351,"startTime":"0","endTime":"0","summary":"公司公告汇总：博拓生物将于9月14日召开第二次临时股东会，审议2026年限制性股票激励计划相关议案。公司公告汇总2026年第二次临时股东会会议资料杭州博拓生物科技股份有限公司将于2026年9月14日召开第二次临时股东会，审议《公司2026年限制性股票激励计划（草案）》及其摘要、《公司2026年限制性股票激励计划实施考核管理办法》及提请股东会授权董事会办理股权激励相关事宜的议案。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090300001807.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688767","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663507158","title":"博拓生物（688767）披露2026年半年度报告，8月31日股价上涨4.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663507158","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663507158?lang=zh_cn&edition=full","pubTime":"2026-08-31 17:49","pubTimestamp":1788169768,"startTime":"0","endTime":"0","summary":"截至2026年8月31日收盘，博拓生物报收于38.61元，较前一交易日上涨4.35%，最新总市值为57.66亿元。该股当日开盘37.0元，最高39.39元，最低34.38元，成交额达1.3亿元，换手率为2.37%。近日，杭州博拓生物科技股份有限公司披露《2026年半年度报告》。利润总额为-23,622,640.42元，较上年同期下降288.26%。经营活动产生的现金流量净额为8,114,371.15元，较上年同期下降82.73%。研发投入占营业收入的比例为23.86%，较上年同期增加4.19个百分点。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100025221.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688767","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663047297","title":"股市必读：博拓生物中报 - 第二季度单季净利润同比下降272.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663047297","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663047297?lang=zh_cn&edition=full","pubTime":"2026-08-31 06:08","pubTimestamp":1788127695,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘，博拓生物报收于37.0元，上涨0.82%，换手率1.29%，成交量1.93万手，成交额7102.2万元。业绩披露要点：2026年中报显示归母净利润为-1655.26万元，同比下降233.46%；第二季度扣非净利润同比下降1806.44%。其中第二季度主营收入1.25亿元，同比上升8.59%；归母净利润-634.47万元，同比下降272.88%；扣非净利润-785.49万元，同比下降1806.44%；负债率10.85%，投资收益-155.48万元，财务费用2032.25万元，毛利率47.06%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100001516.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688767"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663455048","title":"博拓生物（688767）2026年中报简析：增收不增利，三费占比上升明显","url":"https://stock-news.laohu8.com/highlight/detail?id=2663455048","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663455048?lang=zh_cn&edition=full","pubTime":"2026-08-30 06:19","pubTimestamp":1788041940,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期博拓生物发布2026年中报。截至本报告期末，公司营业总收入2.15亿元，同比上升5.61%，归母净利润-1655.26万元，同比下降233.46%。本报告期博拓生物三费占比上升明显，财务费用、销售费用和管理费用总和占总营收同比增幅达52.87%。持有博拓生物最多的基金为广发医药创新混合发起式A，目前规模为0.36亿元，最新净值1.0108，较上一交易日下跌1.57%，近一年下跌33.03%。本文数据来源于博拓生物2026年中报，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000002462.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688767","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663501012","title":"博拓生物(688767)6月30日股东户数0.64万户，较上期减少20.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663501012","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663501012?lang=zh_cn&edition=full","pubTime":"2026-08-29 17:11","pubTimestamp":1787994686,"startTime":"0","endTime":"0","summary":"证券之星消息，近日博拓生物披露，截至2026年6月30日公司股东户数为6405.0户，较3月31日减少1697.0户，减幅为20.95%。在医疗器械行业个股中，博拓生物股东户数低于行业平均水平，截至6月30日，医疗器械行业平均股东户数为2.09万户。从股价来看，2026年3月31日至2026年6月30日，博拓生物区间涨幅为6.42%，在此期间股东户数减少1697.0户，减幅为20.95%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082900023337.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688767","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663687018","title":"图解博拓生物中报：第二季度单季净利润同比下降272.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663687018","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663687018?lang=zh_cn&edition=full","pubTime":"2026-08-29 01:55","pubTimestamp":1787939717,"startTime":"0","endTime":"0","summary":"证券之星消息，博拓生物2026年中报显示，上半年度公司主营收入2.15亿元，同比上升5.61%；归母净利润-1655.26万元，同比下降233.46%；扣非净利润-2080.19万元，同比下降404.35%；其中2026年第二季度，公司单季度主营收入1.25亿元，同比上升8.59%；单季度归母净利润-634.47万元，同比下降272.88%；单季度扣非净利润-785.49万元，同比下降1806.44%；负债率10.85%，投资收益-155.48万元，财务费用2032.25万元，毛利率47.06%。财报数据概要请见下图:本文数据来源于博拓生物2026年中报，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082900005456.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688767"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658205839","title":"8月12日博拓生物涨5.00%，广发医药创新混合发起式A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2658205839","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658205839?lang=zh_cn&edition=full","pubTime":"2026-08-12 16:33","pubTimestamp":1786523603,"startTime":"0","endTime":"0","summary":"证券之星消息，8月12日博拓生物涨5.00%，收盘报40.93元，换手率2.93%，成交量4.37万手，成交额1.77亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为广发基金的广发医药创新混合发起式A。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081200027646.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","688767","159938","09939","BK1574","BK0239","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656306955","title":"博拓生物新注册《IMReader型胶体金免疫层析分析处理软件V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2656306955","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656306955?lang=zh_cn&edition=full","pubTime":"2026-08-04 02:29","pubTimestamp":1785781751,"startTime":"0","endTime":"0","summary":"证券之星消息，近日博拓生物（688767）新注册了《IMReader型胶体金免疫层析分析处理软件V1.0》项目的软件著作权。今年以来博拓生物新注册软件著作权1个。结合公司2025年年报财务数据，2025年公司在研发方面投入了8348.08万元，同比增31.31%。通过天眼查大数据分析，杭州博拓生物科技股份有限公司共对外投资了7家企业，参与招投标项目386次；财产线索方面有商标信息105条，专利信息249条，著作权信息2条；此外企业还拥有行政许可435个。数据来源：天眼查APP以上内容为证券之星据公开信息整理，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080400001780.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688767","159180"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654013981","title":"7月27日博拓生物涨8.30%，广发医药创新混合发起式A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2654013981","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654013981?lang=zh_cn&edition=full","pubTime":"2026-07-27 16:43","pubTimestamp":1785141807,"startTime":"0","endTime":"0","summary":"证券之星消息，7月27日博拓生物涨8.30%，收盘报36.39元，换手率2.22%，成交量3.32万手，成交额1.16亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为广发基金的广发医药创新混合发起式A。广发医药创新混合发起式A目前规模为0.36亿元，最新净值0.9699，较上一交易日下跌3.13%，近一年下跌34.99%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072700021007.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09939","BK1574","688767","BK0239","159938","BK1161","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643229894","title":"四张牌集齐一个王炸，博拓生物All in脑机接口","url":"https://stock-news.laohu8.com/highlight/detail?id=2643229894","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2643229894?lang=zh_cn&edition=full","pubTime":"2026-06-15 10:10","pubTimestamp":1781489401,"startTime":"0","endTime":"0","summary":"这一手，博拓生物是加码，是打造脑机接口精神健康诊疗赛道的闭环。2026年3月，博拓生物公告设立脑机接口及脑科学专项产业基金，基金总规模2亿元。这一手，博拓生物是全覆盖，是构建脑机接口产业生态链。","market":"fut","thumbnail":" http://caiji.3g.cnfol.com/colect/202606/15/20260615387507.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202606/15/20260615387507.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20260615/32279406.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0239","688767"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642469153","title":"博拓生物已回购159万股 金额5940万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2642469153","media":"财中社","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2642469153?lang=zh_cn&edition=full","pubTime":"2026-06-09 17:12","pubTimestamp":1780996320,"startTime":"0","endTime":"0","summary":"博拓生物（688767）发布公告，截至2026年6月9日，公司已回购159万股，占总股本的1.0626%，累计回购金额为5940万元，回购价格区间为35元/股至38元/股。2026年一季度，博拓生物实现收入8938万元，归母净利润-1021万元。\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-06-09/doc-iniauzkv1874154.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["688767","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640949744","title":"博拓生物（688767）披露2025年年度权益分派实施后调整回购股份价格上限的公告，6月2日股价上涨1.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640949744","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640949744?lang=zh_cn&edition=full","pubTime":"2026-06-02 22:34","pubTimestamp":1780410859,"startTime":"0","endTime":"0","summary":"近日，杭州博拓生物科技股份有限公司发布《关于2025年年度权益分派实施后调整回购股份价格上限的公告》。公告显示，公司因实施2025年年度权益分派，每股派发现金红利0.7元（含税），根据相关规定对回购股份价格上限进行调整。调整后的回购价格上限自权益分派实施后的除权除息日起生效。回购资金总额不变，仍为不低于10,000万元且不超过20,000万元，回购股份用于员工持股计划或股权激励。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060200047485.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688767","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640950680","title":"博拓生物（688767）披露以集中竞价交易方式首次回购公司股份暨回购进展公告，6月1日股价上涨1.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640950680","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640950680?lang=zh_cn&edition=full","pubTime":"2026-06-01 22:27","pubTimestamp":1780324043,"startTime":"0","endTime":"0","summary":"截至2026年6月1日收盘，博拓生物报收于38.06元，较前一交易日上涨1.6%，最新总市值为56.84亿元。该股当日开盘38.0元，最高39.1元，最低37.78元，成交额达8835.43万元，换手率为1.55%。博拓生物近日披露《关于以集中竞价交易方式首次回购公司股份暨回购进展公告》。本次回购股份用于员工持股计划或股权激励，回购期限为2026年4月9日至2027年4月8日，预计回购金额为10,000万元至20,000万元。截至2026年5月31日，公司尚未实施回购。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060100041141.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688767","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639601204","title":"每周股票复盘：博拓生物（688767）每股派现0.7元","url":"https://stock-news.laohu8.com/highlight/detail?id=2639601204","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2639601204?lang=zh_cn&edition=full","pubTime":"2026-05-31 02:18","pubTimestamp":1780165094,"startTime":"0","endTime":"0","summary":"截至2026年5月29日收盘，博拓生物报收于38.16元，较上周的40.04元下跌4.7%。本周，博拓生物5月28日盘中最高价报41.49元。博拓生物当前最新总市值56.99亿元，在医疗器械板块市值排名63/129，在两市A股市值排名3077/5207。本周关注点公司公告汇总：博拓生物每股派发现金红利0.7元（含税），股权登记日为2026年5月29日。分派对象为截至股权登记日在中国证券登记结算有限责任公司上海分公司登记在册的全体股东。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026053100000516.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688767"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1791635739383,"stockEarnings":[{"period":"1week","weight":-0.0149},{"period":"1month","weight":0.0524},{"period":"3month","weight":0.0651},{"period":"6month","weight":0.1662},{"period":"1year","weight":-0.0386},{"period":"ytd","weight":0.0678}],"compareEarnings":[{"period":"1week","weight":-0.0074},{"period":"1month","weight":-0.0349},{"period":"3month","weight":-0.0456},{"period":"6month","weight":-0.0433},{"period":"1year","weight":-0.0305},{"period":"ytd","weight":-0.0391}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"杭州博拓生物科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"6405人(较上一季度减少20.95%)","perCapita":"23315股","listingDate":"2021-09-08","address":"浙江省杭州市余杭区中泰街道富泰路17号","registeredCapital":"14933万元","survey":" 杭州博拓生物科技股份有限公司的主营业务是即时检测试剂及仪器的研发、生产与销售。公司的主要产品是药物滥用（毒品）检测系列、传染病检测系列、生殖健康检测系列、肿瘤标志物检测系列、心肌标志物检测系列、抗原/抗体生物原料、动物疾病检测平台系列、炎症系列、分子诊断平台系列。","listedPrice":34.55},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"博拓生物(688767)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供博拓生物(688767)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"博拓生物,688767,博拓生物股票,博拓生物股票老虎,博拓生物股票老虎国际,博拓生物行情,博拓生物股票行情,博拓生物股价,博拓生物股市,博拓生物股票价格,博拓生物股票交易,博拓生物股票购买,博拓生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"博拓生物(688767)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供博拓生物(688767)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}